(Circulation. 1999;99:441-447.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Center for Cardiovascular Research, Department of Medicine, and the Department of Cell Biology and Physiology, Washington University School of Medicine, St Louis, Mo.
Correspondence to Anthony J. Muslin, Center for Cardiovascular Research, Box 8086, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110. E-mail amuslin{at}im.wustl.edu
BackgroundRGS family members are GTPase-activating proteins for heterotrimeric Gq and Gi proteins. RGS genes are expressed in heart tissue and in cultured cardiomyocytes. There is evidence that altered RGS gene expression may contribute to the pathogenesis of cardiac hypertrophy and failure.
Methods and ResultsWe investigated the ability of RGS proteins to block G-protein signaling in vivo by using a cultured cardiomyocyte transfection system. Endothelin-1, angiotensin II, and phenylephrine signal through Gq or Gi family members and promote the hypertrophy of cardiomyocytes. We found that phenylephrine-mediated and endothelin-1mediated induction of the atrial natriuretic factor and myosin light chain-2 genes was inhibited in cells that were transfected with RGS4. Phenylephrine-mediated gene induction was not inhibited in cells that were transfected with N128A-RGS4, a point mutant form that lacks GTPase-activating protein activity. Phenylephrine-mediated myofilament organization and cell growth were also blocked in cells by RGS4.
ConclusionsThese results demonstrate that RGS protein can inhibit G-proteinmediated signaling in vivo and suggest that increased expression of RGS protein may be a counterregulatory mechanism to inhibit G protein signaling.
Key Words: hypertrophy genes growth substances atrial natriuretic factor proteins
This article has been cited by other articles:
![]() |
T. Tokudome, I. Kishimoto, T. Horio, Y. Arai, D. O. Schwenke, J. Hino, I. Okano, Y. Kawano, M. Kohno, M. Miyazato, et al. Regulator of G-Protein Signaling Subtype 4 Mediates Antihypertrophic Effect of Locally Secreted Natriuretic Peptides in the Heart Circulation, May 6, 2008; 117(18): 2329 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lee, K. Pal, T. Tasaki, S. Roy, Y. Jiang, J. Y. An, R. Banerjee, and Y. T. Kwon Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway PNAS, January 8, 2008; 105(1): 100 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Romero, M. Y. Zhou, L. L Yanes, M. W Plonczynski, T. R Washington, C. E Gomez-Sanchez, and E. P Gomez-Sanchez Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion J. Endocrinol., August 1, 2007; 194(2): 429 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and H. G. Dohlman Regulation of G Protein and Mitogen-Activated Protein Kinase Signaling by Ubiquitination: Insights From Model Organisms Circ. Res., December 8, 2006; 99(12): 1305 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, T. Anger, J. Su, J. Hao, X. Xu, M. Zhu, A. Gach, L. Cui, R. Liao, and U. Mende Selective Loss of Fine Tuning of Gq/11 Signaling by RGS2 Protein Exacerbates Cardiomyocyte Hypertrophy J. Biol. Chem., March 3, 2006; 281(9): 5811 - 5820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lee, T. Tasaki, K. Moroi, J. Y. An, S. Kimura, I. V. Davydov, and Y. T. Kwon RGS4 and RGS5 are in vivo substrates of the N-end rule pathway PNAS, October 18, 2005; 102(42): 15030 - 15035. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hague, L. S. Bernstein, S. Ramineni, Z. Chen, K. P. Minneman, and J. R. Hepler Selective Inhibition of {alpha}1A-Adrenergic Receptor Signaling by RGS2 Association with the Receptor Third Intracellular Loop J. Biol. Chem., July 22, 2005; 280(29): 27289 - 27295. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Grillet, A. Pattyn, C. Contet, B. L. Kieffer, C. Goridis, and J.-F. Brunet Generation and Characterization of Rgs4 Mutant Mice Mol. Cell. Biol., May 15, 2005; 25(10): 4221 - 4228. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Riddle, R. A. Schwartzman, M. Bond, and P. A. Insel Multi-Tasking RGS Proteins in the Heart: The Next Therapeutic Target? Circ. Res., March 4, 2005; 96(4): 401 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Harris, I. Treskov, M. W. Rowley, S. Heximer, K. Kaltenbronn, B. N. Finck, R. W. Gross, D. P. Kelly, K. J. Blumer, and A. J. Muslin G-Protein Signaling Participates in the Development of Diabetic Cardiomyopathy Diabetes, December 1, 2004; 53(12): 3082 - 3090. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Hardt and J. Sadoshima Negative regulators of cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 500 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mittmann, C. H. Chung, G. Hoppner, C. Michalek, M. Nose, C. Schuler, A. Schuh, T. Eschenhagen, J. Weil, B. Pieske, et al. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure Cardiovasc Res, September 1, 2002; 55(4): 778 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Patten, J. Bunemann, B. Thoma, E. Kramer, M. Thoenes, S. Stube, C. Mittmann, and T. Wieland Endotoxin induces desensitization of cardiac endothelin-1 receptor signaling by increased expression of RGS4 and RGS16 Cardiovasc Res, January 1, 2002; 53(1): 156 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.J Owen, P.B.J Burton, A.J Mullen, E.J Birks, P Barton, and M.H Yacoub Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure Eur. Heart J., June 2, 2001; 22(12): 1015 - 1020. [Abstract] [PDF] |
||||
![]() |
Y. Takeishi, T. Jalili, B. D. Hoit, D. L. Kirkpatrick, L. E. Wagoner, W. T. Abraham, and R. A. Walsh Alterations in Ca2+ cycling proteins and G{alpha}q signaling after left ventricular assist device support in failing human hearts Cardiovasc Res, March 1, 2000; 45(4): 883 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Wu, Q Zeng, K. Blumer, and A. Muslin RGS proteins inhibit Xwnt-8 signaling in Xenopus embryonic development Development, January 7, 2000; 127(13): 2773 - 2784. [Abstract] [PDF] |
||||
![]() |
C. Pellieux, T. Sauthier, A. Domenighetti, D. J. Marsh, R. D. Palmiter, H.-R. Brunner, and T. Pedrazzini Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors PNAS, February 15, 2000; 97(4): 1595 - 1600. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |